**AI医学成像初创公司AZmed成功斩获1500万欧元A轮融资**
法国医疗科技领域的创新之星AZmed近日宣布，公司已顺利完成1500万欧元的A轮融资，投资方阵容强大，包括Maison Worms、Techstars和Tempact Ventures等知名投资机构。此轮融资将为AZmed的未来发展注入强劲动力，进一步推动其人工智能技术在医学成像领域的应用。
AZmed的核心产品是一款名为Rayvolve的AI软件，该软件专为放射科医生和急诊医生设计，旨在提升诊断效率和准确性。Rayvolve能够自动识别标准放射照相中的各种异常情况，从而减少医生的工作负担，加速检查结果的解释，同时显著降低了因人为因素导致的诊断错误风险。
据Tech.eu报道，AZmed的这一创新技术有望彻底改变医学影像分析的现状，提高医疗服务的质量和效率。随着这笔资金的到位，AZmed预计将加速产品开发，扩大市场覆盖面，并可能进一步探索与其他医疗机构和科技公司的合作机会，以共同推进医疗AI技术的革新。
AZmed的A轮融资成功，不仅彰显了投资者对其技术潜力和市场前景的信心，也标志着AI在医疗领域的应用正逐步深入，成为提升医疗服务质量的关键驱动力。未来，AZmed将持续致力于利用人工智能技术优化医疗诊断流程，为全球医疗行业带来更高效、更精准的解决方案。
英语如下：
**AI Medical Imaging Startup AZmed Secures €15 Million in Funding, Rayvolve Aids in Precise Diagnostics**
Keywords: AZmed, AI medical imaging, €15 million funding
**French AI Medical Imaging Startup AZmed Raises €15 Million in Series A Round**
AZmed, a rising star in the French medical technology sector, has recently announced the successful completion of a €15 million Series A funding round, backed by prominent investors such as Maison Worms, Techstars, and Tempact Ventures. This financial boost will fuel the company’s growth and accelerate the application of its artificial intelligence (AI) technology within the field of medical imaging.
At the heart of AZmed’s offerings is its AI software, Rayvolve, tailored for radiologists and emergency physicians to enhance diagnostic efficiency and accuracy. Rayvolve automatically identifies various abnormalities in standard radiographs, alleviating the workload for medical professionals, expediting interpretation of examination results, and significantly reducing the risk of diagnostic errors due to human factors.
According to Tech.eu, AZmed’s innovative technology has the potential to revolutionize medical image analysis, improving the quality and efficiency of healthcare services. With the new capital, the company expects to accelerate product development, broaden its market reach, and explore potential collaborations with other healthcare institutions and tech companies to further advance medical AI innovation.
The successful Series A funding underscores investors’ confidence in AZmed’s technological potential and market prospects, underscoring the growing role of AI in enhancing medical service quality. Moving forward, AZmed remains committed to leveraging AI to optimize diagnostic processes, delivering more efficient and precise solutions to the global healthcare industry.
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 1